Barely Significant
← all excerpts

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin.

Front Oncol · 2014 · PMC4214226 · PMID 25401086

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantp < 0.05actually significant
At 10 μM, B02 was moderately toxic (20–24% killing), which was nominally significant for all lines tested ( p < 0.05, Figures 1 C,D and Figure S2 in Supplementary Material) except U266 ( p > 0.05; Figure S2 in Supplementary Material), which was also the cell line least sensitized to DOX by B02.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.